Julie M. Cherrington - Jan 19, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Director
Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 19, 2022
Transactions value $
-$171,203
Form type
4
Date filed
1/20/2022, 03:57 PM
Previous filing
Jan 18, 2022
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$171K -1.48K -36.68% $116.07 2.55K Jan 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.